by NDNR-emmabelle-2026. | Oct 1, 2026 | 2026 | October: Men's Health, Pain & Physical Medicine
Share This ArticleExamining the links between testosterone deficiency, endothelial dysfunction, hypertension, and atherosclerosis—and what the TRAVERSE trial and TRT-associated erythrocytosis reveal about cardiovascular risk. I. Introduction Testosterone has...
by NDNR-emmabelle-2026. | Oct 1, 2026 | 2026 | October: Men's Health, Pain & Physical Medicine
Share This ArticleA Nearly Tenfold Rise in Total Motile Sperm Count After Analgesic Discontinuation and Integrative Care An integrative case explores a marked improvement in semen parameters following discontinuation of concentrated analgesic exposure and...
by NDNR-emmabelle-2026. | Oct 1, 2026 | 2026 | October: Men's Health, Pain & Physical Medicine
Share This ArticleHow shifts in testosterone, estrogen, cortisol, vasopressin, and prolactin may influence paternal mental health—and inform screening and individualized naturopathic care during pregnancy and postpartum. Introduction The perinatal and postpartum...
by NDNR-emmabelle-2026. | Oct 1, 2026 | 2026 | October: Men's Health, Pain & Physical Medicine
Share This ArticleA first-in-class NaV1.8 inhibitor offers a targeted approach to acute pain without engaging central opioid receptors, opening new possibilities for non-opioid prescribing and integrative pain management. Suzetrigine is a first-in-class, non-opioid...
by NDNR-emmabelle-2026. | Sep 2, 2026 | 2026 | September: Oncology, Nutrition and Mito Health
Share This ArticleThe pan-RAS(ON) inhibitor daraxonrasib represents an emerging advance in metastatic pancreatic ductal adenocarcinoma. This review examines its mechanism, clinical evidence, adverse effects, and implications for evidence-informed supportive care and...